human embryonic stem cell-derived retinal pigment epithelium
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for human embryonic stem cell-derived retinal pigment epithelium, covering 2018-01-31 to 2018-01-31. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases [Phase 1, Phase 2]